U.S. sinks another $2.1 billion into a potential vaccine

  • Jul. 31, 2020 10:30 a.m.

LONDON — Pharma giants GlaxoSmithKline and Sanofi Pasteur have announced they will supply 100 million doses of an experimental COVID-19 vaccine to the United States as governments buy up supplies in hopes of securing a candidate that works.

The United States will pay up to $2.1 billion “for development including clinical trials, manufacturing, scale-up and delivery” of the vaccine, the two companies based in Europe said in a statement. Sanofi will get the bulk of the funds.

The U.S. government has a further option for the supply of an additional 500 million doses longer term as part of its Operation Warp Speed program.

“The portfolio of vaccines being assembled for Operation Warp Speed increases the odds that we will have at least one safe, effective vaccine as soon as the end of this year,” U.S. Health and Human Services Secretary Alex Azar said in a statement. “Today’s investment supports the Sanofi and GSK adjuvanted product all the way through clinical trials and manufacturing, with the potential to bring hundreds of millions of safe and effective doses to the American people.”

Earlier this week the British government signed a deal for 60 million doses of a potential coronavirus vaccine that could start to be rolled out in the first half of next year.

The vaccine being developed by Britain’s GSK and France’s Sanofi’s is based on existing DNA-based technology that is used to produce Sanofi’s seasonal flu vaccine. It is one of several vaccines in development.

“The global need for a vaccine to help prevent COVID-19 is massive, and no single vaccine or company will be able to meet the global demand alone,” said Thomas Triomphe, executive vice-president of Sanofi Pasteur.

The executive arm of the European Union issued a statement later Friday saying it had concluded exploratory talks with Sanofi to “provide for an option for all EU member states to purchase the vaccine.” The idea would be to offer a contractual framework for the purchase of 300 million doses should the vaccine work.

“We are in advanced discussions with several other companies,” European Commission President Ursula von der Leyen said. “While we do not know today which vaccine will work best in the end, Europe is investing in a diversified portfolio of promising vaccines, based on various types of technologies. This increases our chances to obtain rapidly an effective remedy against the virus.”

Get local stories you won't find anywhere else right to your inbox.
Sign up here

Just Posted

UPDATED: Donations pour in for family of doctor killed in Red Deer attack

More than $100k raised as of Tuesday at 3:40 p.m.

Colleague says Red Deer physician who died was family man, good doctor

Monday’s attack is a shock to Red Deer health community

Doctor who died Monday in Red Deer knew the attacker: RCMP

Red Deer doctor was attacked in his walk-in clinic Monday

IN-DEPTH: Physicians often face aggressive patients

Almost all say they have been abused by patients or their families at some point

Central Alberta man charged with killing Red Deer doctor to appear in court

RED DEER, Alta. — A man accused of killing a family doctor… Continue reading

Alberta reports 257 new cases of COVID-19

The Alberta government reported 257 new cases of COVID-19 in its latest… Continue reading

Cast your votes for Best of Red Deer

The Advocate’s Best of Red Deer Readers’ Choice Awards are back. Community… Continue reading

Hank Williams Jr., Marty Stuart to join Country Hall of Fame

NASHVILLE — Hank Williams Jr., Marty Stuart and songwriter Dean Dillon are… Continue reading

Broadway musical ‘Diana’ to bypass closed stage for Netflix

NEW YORK — The Broadway musical “Diana” isn’t waiting for theatres to… Continue reading

Stocks open higher, pushing S&P 500 closer to record high

Stocks are opening higher on Wall Street Wednesday, bouncing back from a… Continue reading

Belarusian women rally in solidarity with injured protesters

MINSK, Belarus — Nearly 200 women gathered in Belarus’ capital on Wednesday… Continue reading

Biden, Harris to make unusual campaign debut in virus era

WILMINGTON, Del. — Joe Biden is making his first appearance with newly… Continue reading

PM’s ethical conduct in spotlight as Commons sits but Trudeau won’t be there

OTTAWA — Justin Trudeau’s ethical conduct will be put under an opposition… Continue reading

The latest numbers on COVID-19 in Canada for Aug. 12

The latest numbers of confirmed COVID-19 cases in Canada as of 4… Continue reading

Most Read